ID: ALA5195560

Max Phase: Preclinical

Molecular Formula: C17H17N5O

Molecular Weight: 307.36

Associated Items:

Representations

Canonical SMILES:  CC(C)Oc1cc(C#N)ccc1Nc1ncnc2ccn(C)c12

Standard InChI:  InChI=1S/C17H17N5O/c1-11(2)23-15-8-12(9-18)4-5-13(15)21-17-16-14(19-10-20-17)6-7-22(16)3/h4-8,10-11H,1-3H3,(H,19,20,21)

Standard InChI Key:  FOQNSWUDBARUFL-UHFFFAOYSA-N

Associated Targets(Human)

MAP kinase signal-integrating kinase 2 3518 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase-interacting serine/threonine-protein kinase MNK1 2071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Eukaryotic translation initation factor 600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.36Molecular Weight (Monoisotopic): 307.1433AlogP: 3.37#Rotatable Bonds: 4
Polar Surface Area: 75.76Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.43CX Basic pKa: 3.96CX LogP: 3.26CX LogD: 3.26
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -1.33

References

1. Xu W, Kannan S, Verma CS, Nacro K..  (2022)  Update on the Development of MNK Inhibitors as Therapeutic Agents.,  65  (2.0): [PMID:34533957] [10.1021/acs.jmedchem.1c00368]

Source